연구성과로 돌아가기
2023 연구자 정보 (145 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Rizzardini, Giuliano (Rizzardini, G) |
Asst Fatebenefratelli Sacco, Milan, Italy |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Roh, Yoon-Seok (Roh, YS) |
Chungbuk Natl Univ, Cheongju, South Korea |
|
|
[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Rosenthal, Philip (Rosenthal, P) |
Univ Calif San Francisco, San Francisco, CA 94143 USA |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Schwarz, Kathleen B. (Schwarz, KB) |
제1저자 | Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | ||
|
Seo, Yun Jee (Seo, YJ) |
Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Seol, Ho Jun (Seol, HJ) |
Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Seoul, South Korea |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Shalimar (Shalimar) |
All India Inst Med Sci, Delhi, India |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Shin, Sang (Shin, S) |
Samsung Med Ctr, Inst Refractory Canc Res, Res Inst Future Med, Seoul, South Korea |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Shin, Seung Kak (Shin, SK) |
Gachon Univ, Gil Med Ctr, Incheon, South Korea |
|
|
[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Sokal, Etienne M. (Sokal, EM) |
Clin Univ St Luc, Brussels, Belgium |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Song, Jeongeun (Song, J) |
Daegu Catholic Univ, Sch Med, Gyongsan, South Korea Daegu Catholic Univ, Sch Med, Daegu, South Korea |
|
|
[JCR상위 4.5] AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆ [JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Stepanova, Tatyana (Stepanova, T) |
Modern Med Clin, Traralgon, Australia Modern Med Clin, Moscow, Russia |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY [JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; | ||
|
Tamaki, Nobuharu (Tamaki, N) |
Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan |
|
|
[JCR상위 4.5] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net; | ||
|
Tandon, Manish (Tandon, M) |
MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Theodore, Dickens (Theodore, D) |
GSK, Durham, NC USA GSK, Stevenage, Herts, England |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY [JCR상위 1.7] Evidence of durable response to bepirovirsen in B-Clear responders: B-Sure first annual report |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | robert.c.elston@gsk.com; |
페이지 이동: